中/EN Contact/Message
Innovate
Lamzede
Lamzede
departments:内科
drug:注射剂
Active:velmanase alfa-tycv
indication:治疗α-甘露糖苷贮积症的非中枢神经系统表现
Licensor:Chiesi Farmaceutici S.p.A.
Approved Country/Region:FDA
Approval time:2023-02-16